Vinyl terminated polydimethylsiloxane cSt1000, 100g

2-(Trifluoromethyl)quinoline-3-carboxylic acid, 97.0%, 250mg

(S)-1-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)pyrrolidin-3-amine, 97%, 100mg

(-)-Epigallocatechin gallate, 97%, 100g

3-Iodo-4-(piperidin-1-ylmethyl)benzoic acid, 95.0%, 1g

fmoc-pro-opfp, 95.0%, 250mg

Dietilditiocarbamato de plata, mínimo 97 %, pa, 5 g, envase de vidrio

9-([1,1'-Biphenyl]-4-yl)-10-bromoanthracene, 95.0%, 100g

Difluoroacetamide, 98.0%, 1g

3-(Benzyl((benzyloxy)carbonyl)amino)propanoic acid, 95.0%, 25g

methyl 2,4-dioxo-4-pyridin-3-ylbutanoate, 95.0%, 5g

Ethyl 2,4-dioxohexanoate, 95.0%, 25g

3-(2-Chlorophenyl)-3-hydroxypropanoic acid, 98%, 5g